latest news releases from the newsroom
Emisphere Technologies, Inc.
Emisphere Announces Publication of Independent Early-Stage Clinical Study on the Effects of Oral GLP-1 and PYY3-36 On Glucose and Insulin Concentrations
CEDAR KNOLLS, N.J., Oct. 1, 2008 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (Nasdaq:EMIS) today announced the publication of a study assessing the oral delivery of GLP-1 and PYY3-36 using Emisphere's proprietary delivery technology. The study showed, for the first time, that satiety peptides such as GLP-1 and PYY3-36 can be delivered orally in humans with safety and efficiency. This independent study was conducted at University Hospital in Basel, Switzerland by Christoph Beglinger, M.D., of the Clinical Research Center, Department of Biomedicine Division of Gastroenterology, and Department of Clinical Pharmacology and Toxicology at the hospital, and the study results were published in the October 2008 issue of Clinical Pharmacology & Therapeutics.
Market Pulse Announces Its AM Stock Picks for Wednesday, October 1, 2008: WFC, PRRY, ORCL, JAVA
ATLANTA, Oct. 1, 2008 (GLOBE NEWSWIRE) -- Market Pulse is pleased to announce the following stock picks. Bernard Schmitt of Market Pulse states, "These particular stocks should be closely watched due to existing fundamental and technical factors affecting each company." Bernard possesses many years of experience in the financial industry evaluating and picking stocks. He rates them as follows:
Grupo Aeroportuario del Centro Norte S.A.B. de C.V.
OMA to Make Second Dividend Payment for 2007 Results
MONTERREY, Mexico, Oct. 1, 2008 (GLOBE NEWSWIRE) -- Grupo Aeroportuario del Centro Norte, known as OMA, announces details for the payment of the second of the four quarterly dividends with respect to 2007 results that was approved by its annual shareholders' meeting.